Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Pipeline analysis PART 07: Market segmentation by application • Diagnostics • Therapeutics PART 08: Geographical segmentation • Radiopharmaceuticals market in Americas • Radiopharmaceutical market in EMEA • Radiopharmaceuticals market in APAC PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Partnerships for development of radiopharmaceuticals • Production based on cyclotron PART 12: Vendor landscape PART 13: Key vendor analysis • Bayer • Cardinal Health • GE Healthcare • Lantheus Medical Imaging • Other prominent members PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Characteristics of radiopharmaceuticals Exhibit 02: Factors affecting the development of new radiopharmaceutical Exhibit 03: Applications of radiopharmaceuticals Exhibit 04: Advantages and disadvantages of radiopharmaceuticals Exhibit 05: Global radiopharmaceuticals market snapshot Exhibit 06: Global radiopharmaceuticals market 2016-2021 ($ millions) Exhibit 07: Opportunity analysis in global radiopharmaceuticals market Exhibit 08: Five forces analysis Exhibit 09: Key pipeline molecules by vendors Exhibit 10: Key clinical trials Exhibit 11: Segmentation of global radiopharmaceuticals market by application 2016 Exhibit 12: Segmentation of global radiopharmaceuticals market by application 2016 and 2021 (%) Exhibit 13: Global radiopharmaceutical diagnostics market 2016-2021 ($ millions) Exhibit 14: Diagnostic radiopharmaceuticals used in various clinical practices Exhibit 15: Techniques of radiopharmaceutical imaging Exhibit 16: Global radiopharmaceutical therapeutics market 2016-2021 ($ millions) Exhibit 17: Commonly used radiopharmaceuticals for targeted radionuclide therapy Exhibit 18: Treatment of tumors and cancers with radioisotopes Exhibit 19: Segmentation of global radiopharmaceuticals market based on geography 2016 and 2021 (%) Exhibit 20: Segmentation of global radiopharmaceuticals market revenue by geography 2016-2021 ($ millions) Exhibit 21: Segmentation of global radiopharmaceuticals market share by geography 2016-2021 (%) Exhibit 22: Market scenario in Americas Exhibit 23: Radiopharmaceuticals market in Americas 2016-2021 ($ millions) Exhibit 24: Radiopharmaceuticals market scenario in EMEA Exhibit 25: Radiopharmaceuticals market in EMEA 2016-2021 ($ millions) Exhibit 26: Radiopharmaceuticals market scenario in APAC Exhibit 27: Radiopharmaceuticals market in APAC 2016-2021 ($ millions) Exhibit 28: Functions of JRIA Exhibit 29: Facts about the neurological disorders Exhibit 30: Problems associated with the radiopharmaceutical drugs Exhibit 31: Competitive structure analysis of the global pharmaceutical market 2016 Exhibit 32: Bayer: Key highlights Exhibit 33: Bayer: Strength assessment Exhibit 34: Bayer: Strategy assessment Exhibit 35: Bayer: opportunity assessment Exhibit 36: Cardinal Health: Key highlights Exhibit 37: Cardinal Health: Strength assessment Exhibit 38: Cardinal Health: Strategy assessment Exhibit 39: Cardinal Health: Opportunity assessment Exhibit 40: GE Healthcare: Key highlights Exhibit 41: GE Healthcare: Strength assessment Exhibit 42: GE Healthcare: Strategy assessment Exhibit 43: GE Healthcare: Opportunity assessment Exhibit 44: Lantheus Medical Imaging: Key highlights Exhibit 45: Lantheus Medical Imaging: Strength assessment Exhibit 46: Lantheus Medical Imaging: Strategy assessment Exhibit 47: Lantheus Medical Imaging: Opportunity assessment

Bayer, Cardinal Health, GE Healthcare, Lantheus Medical Imaging, ABT Molecular Imaging, Advanced Accelerator Applications, Algeta, Eczacibasi-Monrol Nuclear Products, FUJIFILM Holdings, Isologic Innovative Radiopharmaceuticals, Nordion, Piramal Imaging, RadioMedix, and Triad Isotopes.